• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
CONCLUSION: Novel immunotherapies are needed in cancer patients with resistance to or relapse after current immunotherapeutic drugs. Such new treatments may include targeted agents or monoclonal antibodies to overcome the immune-suppressive tumor microenvironment. The mode of combining the novel treatments, including vaccines, needs to be matched to the patient's immune status for achieving the maximum benefit. In this scenario, specific attention should be also paid nowadays to the immune intersection between COVID-19 and cancer.PMID:34301276 | DOI:10.1186/s13046-021-02023-4
Source: Cell Research - July 24, 2021 Category: Cytology Authors: Michele Maio Michael Lahn Anna Maria Di Giacomo Alessia Covre Luana Calabr ò Ramy Ibrahim Bernard Fox Siena Think Tank Source Type: research

HPV vaccine acceptance in West Africa: A systematic literature review
Vaccine. 2021 Aug 5:S0264-410X(21)00835-5. doi: 10.1016/j.vaccine.2021.06.074. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) infections are mostly sexually transmitted and cause the greatest share of infection-associated cancers. Each year more than half a million women are diagnosed with cervical cancer and the mortality rate in West Africa is over ten times higher than that of Northern Europe. HPV vaccines are highly effective at preventing various strains of the infection. However, vaccine hesitancy and access issues have led to low HPV vaccine acceptance in certain countries. A search strategy was developed ...
Source: Vaccine - August 9, 2021 Category: Allergy & Immunology Authors: Rose Wilson Source Type: research

Novel treatments in BCG failure. Where do we stand today?
CONCLUSIONS: Results from ongoing trials will provide us useful information about many of the existing regimens and probably new drugs will soon be available for this group of patients.PMID:34472437
Source: Archivos Espanoles de Urologia - September 2, 2021 Category: Urology & Nephrology Authors: Charalampos Fragkoulis Ioannis Glykas Aristotelis Bamias Georgios Stathouros Georgios Papadopoulos Konstantinos Ntoumas Source Type: research

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Novel treatments in BCG failure. Where do we stand today?
CONCLUSIONS: Results from ongoing trials will provide us useful information about many of the existing regimens and probably new drugs will soon be available for this group of patients.PMID:34472437
Source: Archivos Espanoles de Urologia - September 2, 2021 Category: Urology & Nephrology Authors: Charalampos Fragkoulis Ioannis Glykas Aristotelis Bamias Georgios Stathouros Georgios Papadopoulos Konstantinos Ntoumas Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20